Views & Analysis Value-based healthcare: What’s it worth to you? It takes healthy people to make a healthy society – and that must be taken into account when we are talking about value-based healthcare.
Partner Content Partner Content How challenges like Brexit & insufficient patients hinde... Challenges facing Orphan Drugs & Rare Diseases Research
Debates & Insight Sponsored UK pharma and integrated health The concept of integrated healthcare is not new to the UK, where it has been discussed since the late 1960s.
Partner Content Partner Content The Conference Forum Launches 2017 Clinical Trial Collaborat... The 2nd annual Clinical Trial Collaborations event
News Lilly bags FDA okay for Wegovy pill rival orforglipron Eli Lilly has claimed US approval for oral GLP-1 agonist orforglipron, setting up a market clash with Novo Nordisk's first-to-market Wegovy pill.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.